BUTALEX Profile



Product

product image
BUTALEX
Company
Sarabhai Zydus Animal Health Limited
Group
Allopathic
Subgroup
Anti haemoprotozoans Drugs
Main Combination
Buparvaquone
Storage
Room Temparature
Type
Injection  
Packing
Packing
Mrp
Tax
20 ml   
Rs 0   
+ inc.tax   
Indication
Butalex is indicated for the treatment of theileriosis in exotic as well as cross bred cattle and calves, caused by strains of T.annulata and T.orientalis(seargenti)

Butalex is active against both the schizont and piroplasm stages of theileria species and may be used in the incubation period of the disease or when clinical signs are apparent.  Treatment with Butalex should be given to clinically affected animals and to in-contact animals which may be infected but are not showing clinical signs.

Composition
Each ml contains:
Buparvaquone   : 50 mg
(ina solvent vehicle)
Dosage
Canine:
N/A
Sheep
N/A
Poultry
N/A
Large Animals
1 ml per 20 kg b.w. by I/M route
A single injection of 1 ml Butalex per 20 kg b.w. (2.5 mg buparvaquone per kg) is usually sufficient.
In severe cases, a further treatment with Butalex, at the same dose rate of 1 ml per 20 kg b.w. may be required.  Normally this should be given within 48-72 hours of the initial injection.
Others
1 ml per 20 kg b.w. by I/M route
A single injection of 1 ml Butalex per 20 kg b.w. (2.5 mg buparvaquone per kg) is usually sufficient.
In severe cases, a further treatment with Butalex, at the same dose rate of 1 ml per 20 kg b.w. may be required.  Normally this should be given within 48-72 hours of the initial injection.
Administration
By I/M route
Advantages
N/A
Precautions
Butalex should not be given by intravenous or subcutaneous injection.  Localised, painless, oedematous, swelling may occasionally be seen at the injection site especially in thin skinned animals.
Milk taken from lactating animals during the 48 hours immediately, following the treatment with Butalex should not  be used for human consumption.  Animals should not  be slaughtered for human consumption within 42 days of the last treatment.
Go Back